📈MarketsRocket Pharmaceuticals Maintains Hold Rating as Analysts Watch for Clinical Validation
Market analysts are maintaining a cautious hold rating on Rocket Pharmaceuticals, emphasizing the need for upcoming clinical validation despite encouraging progress.